Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi‐center, randomized, active controlled trial

Claudia Trenkwalder(Paracelsus Elena Klinik Kassel), Svenja Happe(Klinikum Bremen-Mitte), Ralf Kohnen(Friedrich-Alexander-Universität Erlangen-Nürnberg), Birgit Högl(Innsbruck Medical University), Johannes Mathis(University Hospital of Bern), Heike Beneš(Siesta Group (Austria)), G. Saletu‐Zyhlarz(Vienna General Hospital), Ludger Grote(Sahlgrenska University Hospital)
Movement Disorders
February 3, 2007
Cited by 106


Related Papers